News Archive

New budget forms for HIV/AIDS proposals

Published on 14 March 2008 in 'Announcements'

Every application sent to EDCTP should be accompanied by a budget form (in Excel) and a statement that the project can be carried out for the budget requested.

Launch of call to fund small EDCTP projects

Published on 4 March 2008 in 'Announcements'

EDCTP has launched a call for short proposals in support of general activities whitin the EDCTP scope.

EDCTP Newsletter January 2008

Published on 25 January 2008 in 'Announcements'

The EDCTP January 2008 Newsletter has been sent early January, and is now also available in French and Portuguese on the website.

EDCTP is looking for experts of HIV/AIDS grant applications

Published on 23 January 2008 in 'Announcements'

Between June and August 2008, the applications for EDCTP grants for HIV/AIDS treatment, vaccines and microbicides will be reviewed.

EDCTP launches call for proposals on HIV vaccines

Published on 11 December 2007 in 'Announcements'

On 1 December 2007, EDCTP launched two calls for proposals: one for HIV treatment and one for microbicides. EDCTP is pleased to announce a third call in the area of HIV/AIDS:

1 December 2007 World AIDS Day: EDCTP launches € 12.6 M grants for HIV treatment and microbicides

Published on 1 December 2007 in 'Announcements'

Every year on 1 December, the world commemorates World AIDS Day. Given that sub-Saharan Africa bears the brunt of this disease the current focus of EDCTP is in this region. EDCTP wishes to make a contribution to mitigating the effect of this disease by announcing funding opportunities for HIV/AIDS researchers. To commemorate the occasion EDCTP is happy to announce the launch of two calls for proposals; one on HIV/AIDS treatment and the other on microbicides (total € 12 M).

EDCTP Calls and Grants 2004-now

Published on 26 November 2007 in 'Announcements'

To date EDCTP has launched around 30 calls for proposals in the field of HIV/AIDS, malaria and tuberculosis, and committed to fund 74 projects that include clinical trials, capacity development and support of networks.

HIV/AIDS infected children can now benefit from a European and Developing Countries Clinical Trials Partnership (EDCTP) funded trial

Published on 14 September 2007 in 'Press Releases'

In August, the United States (US) Food and Drug Administration (FDA) gave a tentative approval to a fixed-dose anti-HIV drug specifically formulated for paediatric use. The fixed-dose combination scored tablet of lamivudine 30mg, stavudine 6mg and nevirapine 50mg (Triomune Baby) and double this strength (Triomune Junior) is manufactured by CIPLA pharmaceuticals. It is administered twice daily, according to a simple weight-based table, allowing for easy prescribing. It can also be ‘snapped in half’ and dissolved in water for young children who cannot swallow tablets. As a result of this tentative approval, this FDC antiretroviral drug will be included in the World Health Organisation (WHO) Prequalification Programme and will become available for distribution under the Presidents Emergency Plan for AIDS relief (PEPFAR) and Clinton Foundation programmes.

Cofunding by Norway of EDCTP vaccines calls for proposals

Published on 12 September 2007 in 'Announcements'

The Research Council of Norway (RCN) will, through the Programme for Global Health and Vaccination Research (GLOBVAC), make co-funding available for proposals with the participation of Norwegian research institutions in the upcoming EDCTP calls for proposals on vaccines development (malaria, TB and HIV).

Cofunding by The Netherlands of the EDCTP Call for Proposals for Regional Networks of Excellence in sub-Saharan Africa

Published on 5 September 2007 in 'Announcements'

The Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP) has announced that it will provide €3,000,000 in cofunding for the EDCTP Call for Proposals for Regional Networks of Excellence in sub-Saharan Africa.

Displaying results 31 to 40 out of 65

< Previous

Next >